The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity

O-1602 and O-1918 are atypical cannabinoid ligands for GPR55 and GPR18, which may be novel pharmaceuticals for the treatment of obesity by targeting energy homeostasis regulation in skeletal muscle. This study aimed to determine the effect of O-1602 or O-1918 on markers of oxidative capacity and fat...

Descripción completa

Detalles Bibliográficos
Autores principales: Simcocks, Anna C., O’Keefe, Lannie, Jenkin, Kayte A., Cornall, Lauren M., Grinfeld, Esther, Mathai, Michael L., Hryciw, Deanne H., McAinch, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460607/
https://www.ncbi.nlm.nih.gov/pubmed/32824681
http://dx.doi.org/10.3390/ijms21165922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460607/
https://www.ncbi.nlm.nih.gov/pubmed/32824681
http://dx.doi.org/10.3390/ijms21165922

Ejemplares similares